Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01929720 · ClinicalTrials.gov registry record · NA

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

A NA study of Depression and Pain, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01929720 is a NA study of Depression and Pain that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 33 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01929720, a NA study of Depression and Pain, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial studies a cognitive-behavioral intervention to treat worry, uncertainty, and insomnia in cancer survivors. Counseling may reduce anxiety and insomnia as well as improve the well-being and quality of life of cancer survivors. This study also explores the neuro-immunologic correlates of anxiety and insomnia.

Interventions

  • BEHAVIORAL Cognitive-behavioral therapy for worry, uncertainty & insomnia

Study Locations (1)

Ohio

  • Wexner Medical Center at The Ohio State University Department of Psychiatry - Columbus

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2011-08
Est. Completion 2014-09
Phase NA

What the Registry Record Tells You About NCT01929720

The ClinicalTrials.gov registry entry for NCT01929720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Cognitive-behavioral therapy for worry, uncertainty & insomnia is the first listed.

NCT01929720 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01929720 about?

NCT01929720 is a clinical study titled "Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors". This randomized clinical trial studies a cognitive-behavioral intervention to treat worry, uncertainty, and insomnia in cancer survivors. Counseling may reduce anxiety and insomnia as well as improve the well-being and quality of life of cancer survivors. This study also explores the neuro-immunolog...

What is the current status of trial NCT01929720?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2011-08. Estimated completion is 2014-09.

What conditions does trial NCT01929720 study?

This clinical trial studies the following conditions: Depression, Pain, Insomnia, Fatigue, Anxiety Disorder.

What interventions are being tested in trial NCT01929720?

The interventions under investigation include: Cognitive-behavioral therapy for worry, uncertainty & insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT01929720?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01929720 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.